Xpert Hemorrhagic Fever on Edge X in Trained and Untrained Users

Completed

Conditions studied: Hemorrhagic Fever

In brief

A multi-site observation study that was conducted in the United States at 3 CLIA Waived sites with Untrained Users testing on Xpert Hemorrhagic fever tests on Edge X instruments

Key facts

Study ID

NCT07591740

Run by

Cepheid

People needed

725

Starts

2024-10-21

Expected to finish

2026-03-13

Last updated by the study team

2026-05-18

Who can join

Age: 14 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Capillary and venous whole blood specimens from individuals asymptomatic for fever
• Whole blood specimens collected in EDTA specimens collection devices only- Whole Blood specimens collected in EDTA specimen collection devices only

You may not qualify if…

• Participants vaccinated with a Hemorrhagic Fever live virus vaccine within the past 28 days.
• Participant was previously enrolled into this protocol. • VWB and CWB specimens were not collected according to the manufacturer's instructions.

Where it is running

• No-Resistance Consulting Group — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.